Latest Healthcare Research Reports

Tag: fibromyalgia treatment market forecast

  • Fibromyalgia Treatment Market Revenue Anticipated To Reach $3.66 Billion By 2030 With 5% CAGR

    Fibromyalgia Treatment Market Revenue Anticipated To Reach $3.66 Billion By 2030 With 5% CAGR

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    How Will The Market Size Of The Fibromyalgia Treatment Market Progress Through 2030?

    The size of the fibromyalgia treatment market has experienced continuous growth over recent years. It is projected to expand from $2.89 billion in 2025 to $3.01 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 4.2%. Historically, this expansion has been driven by factors such as a rise in the diagnosis of chronic pain disorders, the availability of antidepressants and antiepileptics, enhanced healthcare access, the proliferation of pain clinics, and improved awareness of the disease.

    The fibromyalgia treatment market size is expected to see strong growth in the next few years. It will grow to $3.67 billion in 2030 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to development of targeted pain therapies, growth in personalized treatment plans, increased adoption of digital pain management tools, expansion of integrative therapies, rising mental health awareness. Major trends in the forecast period include rising use of symptom-based drug therapies, increased adoption of multimodal treatment approaches, growing focus on chronic pain management, expansion of non-pharmacological therapies, improved patient-centered care models.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12933&type=smp

    What Market Drivers Are Helping Shape The Fibromyalgia Treatment Market Expansion?

    An expanding elderly demographic is anticipated to fuel expansion within the fibromyalgia treatment market. This demographic trend signifies an increasing share of older individuals within a given society or group. Fibromyalgia interventions are especially beneficial for the older demographic as they are more prone to developing the condition and frequently face exacerbated symptoms due to factors associated with age. As an illustration, Age UK, a UK-registered charity, reported that in 2023, England had 11 million individuals aged over 65. This number is forecast to rise by 10% over the subsequent five years and by 32% by 2043, representing 1.1 and 3.5 million people, respectively. Furthermore, the 85+ age group, which is the most probable demographic to require health and care provisions, is expected to grow quickly, showing an increase of 8.2% in the next five years and 62.7% by 2043, accounting for 126,000 and 956,000 people, respectively. Consequently, the expanding aging population acts as a catalyst for the expansion of the fibromyalgia treatment market.

    How Is The Fibromyalgia Treatment Market Structured Across Different Market Segments?

    The fibromyalgia treatment market covered in this report is segmented –

    1) By Type: Symptomatic Treatment, Targeted Treatment

    2) By Drug Class: Antidepressants, Antiepileptics, Muscle Relaxants, Analgesics, Other Drugs

    3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

    Subsegments:

    1) By Symptomatic Treatment: Pain Relievers, Antidepressants, Anti-seizure Medications, Sleep Aids, Physical Therapy

    2) By Targeted Treatment: Cognitive Behavioral Therapy (CBT), Lifestyle Modifications, Complementary Therapies, Medications Targeting Specific Symptoms

    What Trends Are Influencing The Fibromyalgia Treatment Market?

    Leading companies in the fibromyalgia treatment market are prioritizing the development of technologically advanced solutions, such as computerized behavioral therapy devices, to achieve a competitive edge. These devices are software-based prescription treatments that deliver structured psychological interventions, including Acceptance and Commitment Therapy (ACT), via a digital platform. For example, in May 2023, Swing Therapeutics, a U.S.-based digital therapeutics company, secured FDA De Novo authorization for Stanza. This prescription smartphone-based digital therapy offers a 12-week self-guided ACT program, which demonstrated significant improvements in pain, fatigue, sleep, and mood during its pivotal PROSPER-FM Phase 3 trial. Stanza is made available through Swing Care, a virtual specialty clinic integrating prescription digital therapy with comprehensive fibromyalgia management. This trend not only enhances patient access and reduces reliance on pharmacologic treatments but also aligns with guideline-driven non-drug care, although challenges remain in scaling reimbursement and clinician adoption.

    Which Companies Form The Competitive Landscape Of The Fibromyalgia Treatment Market?

    Major companies operating in the fibromyalgia treatment market are Pfizer Inc., Johnson and Johnson Services Inc., AbbVie Inc., Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Co. Ltd., Sun Pharmaceutical Industries Ltd., Horizon Therapeutics plc, Endo International plc, Amneal Pharmaceuticals Inc., Zydus Lifesciences Limited, Lupin Limited, Tonix Pharmaceuticals, Allergan plc, Aptinyx Inc., Novartis AG, Merck & Co Inc.

    Access The Complete Fibromyalgia Treatment Market Report:

    https://www.thebusinessresearchcompany.com/report/fibromyalgia-treatment-global-market-report

    Which Geographic Region Represents The Largest Fibromyalgia Treatment Market Share?

    North America was the largest region in the fibromyalgia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fibromyalgia treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access Fibromyalgia Treatment Market Report for Deeper Competitive Insights

    https://www.thebusinessresearchcompany.com/customise?id=12933&type=smp

    Browse Through More Reports Similar to the Global Fibromyalgia Treatment Market 2026, By The Business Research Company

    Neuralgia Treatment Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/neuralgia-treatment-global-market-report

    Muscle Pain Treatment Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/muscle-pain-treatment-global-market-report

    Neurofibromatosis Treatment Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/neurofibromatosis-treatment-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Fibromyalgia Treatment Market Growth Supported by Rising Aging Population

    Fibromyalgia Treatment Market Growth Supported by Rising Aging Population

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    From Its 2026 Market Size, What Value Is The Fibromyalgia Treatment Market Projected To Reach By 2030?

    The fibromyalgia treatment market size has experienced consistent expansion in recent years. It is anticipated to increase from $2.89 billion in 2025 to $3.01 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.2%. The historical development of this market is attributable to a greater diagnosis of chronic pain disorders, the availability of antidepressants and antiepileptics, improved access to healthcare, the proliferation of pain clinics, and enhanced awareness of the disease.

    The fibromyalgia treatment market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $3.67 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.0%. Factors driving this expansion during the projection period encompass advancements in targeted pain therapies, an increase in personalized treatment strategies, greater integration of digital tools for pain management, the proliferation of integrative therapies, and heightened awareness regarding mental health. Prominent trends expected over the forecast horizon involve the increasing utilization of symptom-focused drug treatments, a wider acceptance of multimodal therapeutic strategies, an intensified emphasis on managing chronic pain, the growth of non-pharmacological interventions, and enhanced patient-centric care models.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/report/fibromyalgia-treatment-global-market-report

    Which Factors Are Influencing The Growth Of The Fibromyalgia Treatment Market?

    An increasing elderly demographic is anticipated to fuel the expansion of the fibromyalgia treatment market. This demographic trend describes a growing percentage of older people in a community or general populace. Fibromyalgia interventions prove especially beneficial for older demographics, as seniors are more prone to developing the condition and frequently suffer from harsher symptoms influenced by age-related factors. For example, in 2023, the UK-registered charity Age UK reported that England had 11 million individuals aged over 65. This number is forecast to rise by 10% over the next five years and by 32% by 2043, equating to an additional 1.1 and 3.5 million people, respectively. Furthermore, the population aged 85+, which typically requires the most health and care services, is also expected to grow quickly, with an 8.2% increase in the next five years and a 62.7% increase by 2043, representing 126,000 and 956,000 more individuals, respectively. Consequently, the expanding elderly population is a key factor driving the growth of the fibromyalgia treatment market.

    How Is Segmentation Applied In The Fibromyalgia Treatment Market Segment Analysis?

    The fibromyalgia treatment market covered in this report is segmented –

    1) By Type: Symptomatic Treatment, Targeted Treatment

    2) By Drug Class: Antidepressants, Antiepileptics, Muscle Relaxants, Analgesics, Other Drugs

    3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

    Subsegments:

    1) By Symptomatic Treatment: Pain Relievers, Antidepressants, Anti-seizure Medications, Sleep Aids, Physical Therapy

    2) By Targeted Treatment: Cognitive Behavioral Therapy (CBT), Lifestyle Modifications, Complementary Therapies, Medications Targeting Specific Symptoms

    Which Trends Are Influencing Demand In The Fibromyalgia Treatment Market?

    Leading firms in the fibromyalgia treatment market are prioritizing the creation of cutting-edge solutions, including computerized behavioral therapy devices, to secure a competitive edge. Such a device represents a software-driven prescription therapy, offering structured psychological interventions like Acceptance and Commitment Therapy (ACT) through a digital medium. As an illustration, in May 2023, Swing Therapeutics, a digital therapeutics company based in the U.S., obtained FDA De Novo authorization for Stanza. This prescription smartphone-based digital therapy provides a 12-week self-guided ACT program, which showed notable enhancements in pain, fatigue, sleep, and mood during its crucial PROSPER-FM Phase 3 trial. Stanza is accessible through Swing Care, a virtual specialty clinic that combines prescription digital therapy with thorough fibromyalgia management strategies. This development improves patient accessibility, lessens dependence on pharmacological treatments, and aligns with non-drug care guided by established guidelines, although hurdles persist concerning the expansion of reimbursement and adoption by clinicians.

    Who Are The Companies Participating In The Fibromyalgia Treatment Market Environment?

    Major companies operating in the fibromyalgia treatment market are Pfizer Inc., Johnson and Johnson Services Inc., AbbVie Inc., Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Co. Ltd., Sun Pharmaceutical Industries Ltd., Horizon Therapeutics plc, Endo International plc, Amneal Pharmaceuticals Inc., Zydus Lifesciences Limited, Lupin Limited, Tonix Pharmaceuticals, Allergan plc, Aptinyx Inc., Novartis AG, Merck & Co Inc.

    Get The Full Fibromyalgia Treatment Market Report:

    https://www.thebusinessresearchcompany.com/report/fibromyalgia-treatment-global-market-report

    Which Region Is The Top Contributor To The Fibromyalgia Treatment Market By Share?

    North America was the largest region in the fibromyalgia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fibromyalgia treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Fibromyalgia Treatment Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/fibromyalgia-treatment-global-market-report

    Browse Through More Reports Similar to the Global Fibromyalgia Treatment Market 2026, By The Business Research Company

    Neurofibromatosis Treatment Market Report 2026

    https://www.thebusinessresearchcompany.com/report/neurofibromatosis-treatment-global-market-report

    Neuralgia Treatment Market Report 2026

    https://www.thebusinessresearchcompany.com/report/neuralgia-treatment-global-market-report

    Muscle Pain Treatment Market Report 2026

    https://www.thebusinessresearchcompany.com/report/muscle-pain-treatment-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Fibromyalgia Treatment Market Growth Supported by Rising Aging Population

    Fibromyalgia Treatment Market Growth Supported by Rising Aging Population

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    From Its 2026 Market Size, What Value Is The Fibromyalgia Treatment Market Projected To Reach By 2030?

    The fibromyalgia treatment market size has experienced consistent expansion in recent years. It is anticipated to increase from $2.89 billion in 2025 to $3.01 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.2%. The historical development of this market is attributable to a greater diagnosis of chronic pain disorders, the availability of antidepressants and antiepileptics, improved access to healthcare, the proliferation of pain clinics, and enhanced awareness of the disease.

    The fibromyalgia treatment market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $3.67 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.0%. Factors driving this expansion during the projection period encompass advancements in targeted pain therapies, an increase in personalized treatment strategies, greater integration of digital tools for pain management, the proliferation of integrative therapies, and heightened awareness regarding mental health. Prominent trends expected over the forecast horizon involve the increasing utilization of symptom-focused drug treatments, a wider acceptance of multimodal therapeutic strategies, an intensified emphasis on managing chronic pain, the growth of non-pharmacological interventions, and enhanced patient-centric care models.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/report/fibromyalgia-treatment-global-market-report

    Which Factors Are Influencing The Growth Of The Fibromyalgia Treatment Market?

    An increasing elderly demographic is anticipated to fuel the expansion of the fibromyalgia treatment market. This demographic trend describes a growing percentage of older people in a community or general populace. Fibromyalgia interventions prove especially beneficial for older demographics, as seniors are more prone to developing the condition and frequently suffer from harsher symptoms influenced by age-related factors. For example, in 2023, the UK-registered charity Age UK reported that England had 11 million individuals aged over 65. This number is forecast to rise by 10% over the next five years and by 32% by 2043, equating to an additional 1.1 and 3.5 million people, respectively. Furthermore, the population aged 85+, which typically requires the most health and care services, is also expected to grow quickly, with an 8.2% increase in the next five years and a 62.7% increase by 2043, representing 126,000 and 956,000 more individuals, respectively. Consequently, the expanding elderly population is a key factor driving the growth of the fibromyalgia treatment market.

    How Is Segmentation Applied In The Fibromyalgia Treatment Market Segment Analysis?

    The fibromyalgia treatment market covered in this report is segmented –

    1) By Type: Symptomatic Treatment, Targeted Treatment

    2) By Drug Class: Antidepressants, Antiepileptics, Muscle Relaxants, Analgesics, Other Drugs

    3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

    Subsegments:

    1) By Symptomatic Treatment: Pain Relievers, Antidepressants, Anti-seizure Medications, Sleep Aids, Physical Therapy

    2) By Targeted Treatment: Cognitive Behavioral Therapy (CBT), Lifestyle Modifications, Complementary Therapies, Medications Targeting Specific Symptoms

    Which Trends Are Influencing Demand In The Fibromyalgia Treatment Market?

    Leading firms in the fibromyalgia treatment market are prioritizing the creation of cutting-edge solutions, including computerized behavioral therapy devices, to secure a competitive edge. Such a device represents a software-driven prescription therapy, offering structured psychological interventions like Acceptance and Commitment Therapy (ACT) through a digital medium. As an illustration, in May 2023, Swing Therapeutics, a digital therapeutics company based in the U.S., obtained FDA De Novo authorization for Stanza. This prescription smartphone-based digital therapy provides a 12-week self-guided ACT program, which showed notable enhancements in pain, fatigue, sleep, and mood during its crucial PROSPER-FM Phase 3 trial. Stanza is accessible through Swing Care, a virtual specialty clinic that combines prescription digital therapy with thorough fibromyalgia management strategies. This development improves patient accessibility, lessens dependence on pharmacological treatments, and aligns with non-drug care guided by established guidelines, although hurdles persist concerning the expansion of reimbursement and adoption by clinicians.

    Who Are The Companies Participating In The Fibromyalgia Treatment Market Environment?

    Major companies operating in the fibromyalgia treatment market are Pfizer Inc., Johnson and Johnson Services Inc., AbbVie Inc., Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Co. Ltd., Sun Pharmaceutical Industries Ltd., Horizon Therapeutics plc, Endo International plc, Amneal Pharmaceuticals Inc., Zydus Lifesciences Limited, Lupin Limited, Tonix Pharmaceuticals, Allergan plc, Aptinyx Inc., Novartis AG, Merck & Co Inc.

    Get The Full Fibromyalgia Treatment Market Report:

    https://www.thebusinessresearchcompany.com/report/fibromyalgia-treatment-global-market-report

    Which Region Is The Top Contributor To The Fibromyalgia Treatment Market By Share?

    North America was the largest region in the fibromyalgia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fibromyalgia treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Fibromyalgia Treatment Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/fibromyalgia-treatment-global-market-report

    Browse Through More Reports Similar to the Global Fibromyalgia Treatment Market 2026, By The Business Research Company

    Neurofibromatosis Treatment Market Report 2026

    https://www.thebusinessresearchcompany.com/report/neurofibromatosis-treatment-global-market-report

    Neuralgia Treatment Market Report 2026

    https://www.thebusinessresearchcompany.com/report/neuralgia-treatment-global-market-report

    Muscle Pain Treatment Market Report 2026

    https://www.thebusinessresearchcompany.com/report/muscle-pain-treatment-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Fibromyalgia Treatment Market Analysis for 2026–2030 with Strategic Forecast Insights for Businesses

    Global Fibromyalgia Treatment Market Analysis for 2026–2030 with Strategic Forecast Insights for Businesses

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Will Be The Estimated Market Valuation Of The Fibromyalgia Treatment Market By The End Of 2030?

    The fibromyalgia treatment market has experienced consistent expansion in recent years. This market is projected to grow from $2.89 billion in 2025 to $3.01 billion in 2026, at a compound annual growth rate (CAGR) of 4.2%. The growth observed in the past can be attributed to factors such as an increase in the diagnosis of chronic pain disorders, the availability of antidepressants and antiepileptics, improved healthcare access, the expansion of pain clinics, and enhanced disease awareness.

    The fibromyalgia treatment market size is anticipated to undergo significant growth in the upcoming years. It is projected to expand to $3.67 billion by 2030, achieving a compound annual growth rate (CAGR) of 5.0%. This forecasted growth can be ascribed to advancements in targeted pain therapies, an increase in personalized treatment plans, the wider adoption of digital pain management tools, the proliferation of integrative therapies, and a heightened awareness of mental health. Dominant trends during this period are expected to include a rise in symptom-based drug therapies, greater acceptance of multimodal treatment approaches, an increasing emphasis on chronic pain management, the extension of non-pharmacological therapies, and refined patient-centered care models.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12933&type=smp

    Which Market Drivers Are Supporting The Expansion Of The Fibromyalgia Treatment Market?

    The expanding aging demographic is anticipated to fuel the growth of the fibromyalgia treatment market. An aging population denotes a demographic trend marked by a growing percentage of older people in a community or general populace. Therapies for fibromyalgia are especially beneficial for older people, as seniors are more prone to developing the condition and frequently suffer from more intense symptoms owing to age-specific elements. For instance, in 2023, Age UK, a UK-registered charity, revealed that England had 11 million people aged over 65. This figure is forecast to grow by 10% within the next five years and by 32% by 2043 (representing 1.1 and 3.5 million people, respectively). Furthermore, the demographic group aged 85+, which typically has the highest demand for health and care services, is also anticipated to experience swift growth, rising by 8.2% in the coming five years and by 62.7% by 2043 (equating to 126,000 and 956,000 people, respectively). Consequently, the expanding aging population acts as a catalyst for the growth of the fibromyalgia treatment market.

    Which Segment Classifications Shape The Fibromyalgia Treatment Market?

    The fibromyalgia treatment market covered in this report is segmented –

    1) By Type: Symptomatic Treatment, Targeted Treatment

    2) By Drug Class: Antidepressants, Antiepileptics, Muscle Relaxants, Analgesics, Other Drugs

    3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

    Subsegments:

    1) By Symptomatic Treatment: Pain Relievers, Antidepressants, Anti-seizure Medications, Sleep Aids, Physical Therapy

    2) By Targeted Treatment: Cognitive Behavioral Therapy (CBT), Lifestyle Modifications, Complementary Therapies, Medications Targeting Specific Symptoms

    What Industry Trends Are Redefining The Fibromyalgia Treatment Market?

    Major companies active in the fibromyalgia treatment market are increasingly concentrating on developing technologically advanced solutions, such as computerized behavioral therapy devices, to achieve a competitive advantage. A computerized behavioral therapy device is a software-based prescription treatment that provides structured psychological interventions, like Acceptance and Commitment Therapy (ACT), through a digital platform. For example, in May 2023, Swing Therapeutics, a U.S.-based digital therapeutics company, secured FDA De Novo authorization for Stanza, a prescription smartphone-based digital therapy designed to deliver a 12-week self-guided ACT program; it showed notable improvements in pain, fatigue, sleep, and mood during its crucial PROSPER-FM Phase 3 trial. Stanza is accessible through Swing Care, a virtual specialty clinic that combines prescription digital therapy with thorough fibromyalgia management. This evolution improves patient access, decreases reliance on pharmacologic treatments, and aligns with non-drug care guided by guidelines, despite ongoing difficulties in scaling reimbursement and clinician adoption.

    Which Companies Are Expanding Their Footprint In The Fibromyalgia Treatment Market?

    Major companies operating in the fibromyalgia treatment market are Pfizer Inc., Johnson and Johnson Services Inc., AbbVie Inc., Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Co. Ltd., Sun Pharmaceutical Industries Ltd., Horizon Therapeutics plc, Endo International plc, Amneal Pharmaceuticals Inc., Zydus Lifesciences Limited, Lupin Limited, Tonix Pharmaceuticals, Allergan plc, Aptinyx Inc., Novartis AG, Merck & Co Inc.

    Read the full fibromyalgia treatment market report here:

    https://www.thebusinessresearchcompany.com/report/fibromyalgia-treatment-global-market-report

    How Is The Fibromyalgia Treatment Market Distributed Across Key Geographic Regions?

    North America was the largest region in the fibromyalgia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fibromyalgia treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Fibromyalgia Treatment Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=12933&type=smp

    Browse Through More Reports Similar to the Global Fibromyalgia Treatment Market 2026, By The Business Research Company

    Neuralgia Treatment Global Market Report

    https://www.thebusinessresearchcompany.com/report/neuralgia-treatment-global-market-report

    Muscle Pain Treatment Global Market Report

    https://www.thebusinessresearchcompany.com/report/muscle-pain-treatment-global-market-report

    Neurofibromatosis Treatment Global Market Report

    https://www.thebusinessresearchcompany.com/report/neurofibromatosis-treatment-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Fibromyalgia Treatment Market 2026–2030: Emerging Trends and Forecast Opportunities

    Fibromyalgia Treatment Market 2026–2030: Emerging Trends and Forecast Opportunities

    Uncover key drivers, emerging technologies, and competitive movements shaping the fibromyalgia treatment market from 2026–2035 with trusted insights from The Business Research Company

    How is the Fibromyalgia Treatment Market size predicted to change over the forecast window of 2026–2035?

    The fibromyalgia treatment market size has experienced consistent expansion in recent years. It is anticipated to grow from $2.89 billion in 2025 to $3.01 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 4.2%. This historical growth can be linked to an increased diagnosis of chronic pain disorders, the availability of antidepressants and antiepileptics, rising healthcare access, the expansion of pain clinics, and improved disease awareness.

    The fibromyalgia treatment market size is expected to undergo significant expansion over the next few years. It is predicted to grow to $3.67 billion in 2030, achieving a compound annual growth rate (CAGR) of 5.0%. The projected increase during the forecast period is attributable to the development of specific pain therapies, an increase in personalized treatment plans, greater adoption of digital tools for pain management, the broadening of integrative therapies, and rising awareness about mental health. Important trends identified for the forecast period include an increase in the use of symptom-based drug therapies, a rise in the adoption of multimodal treatment approaches, a stronger focus on chronic pain management, the expansion of non-pharmacological therapies, and improved patient-centered care models.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12933&type=smp

    Which Drivers Are Contributing To The Expansion Of The Fibromyalgia Treatment Market?

    The expanding aging demographic is anticipated to fuel the expansion of the fibromyalgia treatment market. An aging population signifies a demographic shift marked by a growing proportion of older individuals within a society or population. Fibromyalgia treatment is especially beneficial for the aging population because older individuals are more prone to developing fibromyalgia and often suffer from more severe symptoms due to age-related factors. For instance, in 2023, Age UK, a UK-registered charity, reported that 11 million people in England were over 65 years old. This demographic is projected to increase by 10% in the next five years and by 32% by 2043, equating to an additional 1.1 and 3.5 million people, respectively. Furthermore, the population aged 85+, the segment most likely to require health and care services, is also forecast to rise rapidly, growing by 8.2% in the coming five years and by 62.7% by 2043, representing 126,000 and 956,000 people. Therefore, the increase in the aging population is a primary catalyst for the growth of the fibromyalgia treatment market.

    What Segment Categories Are Covered In The Fibromyalgia Treatment Market?

    The fibromyalgia treatment market covered in this report is segmented –

    1) By Type: Symptomatic Treatment, Targeted Treatment

    2) By Drug Class: Antidepressants, Antiepileptics, Muscle Relaxants, Analgesics, Other Drugs

    3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

    Subsegments:

    1) By Symptomatic Treatment: Pain Relievers, Antidepressants, Anti-seizure Medications, Sleep Aids, Physical Therapy

    2) By Targeted Treatment: Cognitive Behavioral Therapy (CBT), Lifestyle Modifications, Complementary Therapies, Medications Targeting Specific Symptoms

    What Trends Are Reshaping The Dynamics Of The Fibromyalgia Treatment Market?

    Leading companies within the fibromyalgia treatment sector are increasingly prioritizing the development of cutting-edge solutions, specifically computerized behavioral therapy devices, to secure a competitive edge. These devices represent software-based prescription treatments designed to deliver structured psychological interventions, such as Acceptance and Commitment Therapy (ACT), through digital platforms. For instance, in May 2023, Swing Therapeutics, a U.S.-based digital therapeutics firm, successfully obtained FDA De Novo authorization for its product, Stanza. Stanza is a smartphone-based digital therapy that provides a self-guided ACT program over 12 weeks, which demonstrated notable enhancements in pain, fatigue, sleep, and mood during its pivotal PROSPER-FM Phase 3 trial. The Stanza program is accessible through Swing Care, a virtual specialty clinic that integrates prescription digital therapy with comprehensive management strategies for fibromyalgia. This particular trend is instrumental in broadening patient access, lessening dependence on pharmaceutical treatments, and aligning with non-pharmacological care guidelines, although difficulties persist concerning the scalability of reimbursement and the widespread adoption by clinicians.

    Which Leading Companies Dominate The Fibromyalgia Treatment Market Share?

    Major companies operating in the fibromyalgia treatment market are Pfizer Inc., Johnson and Johnson Services Inc., AbbVie Inc., Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Co. Ltd., Sun Pharmaceutical Industries Ltd., Horizon Therapeutics plc, Endo International plc, Amneal Pharmaceuticals Inc., Zydus Lifesciences Limited, Lupin Limited, Tonix Pharmaceuticals, Allergan plc, Aptinyx Inc., Novartis AG, Merck & Co Inc.

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/fibromyalgia-treatment-global-market-report

    Which Region Is Anticipated To See The Fastest Growth In The Fibromyalgia Treatment Market?

    North America was the largest region in the fibromyalgia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fibromyalgia treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Fibromyalgia Treatment Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=12933&type=smp

    Browse Through More Reports Similar to the Global Fibromyalgia Treatment Market 2026, By The Business Research Company

    Neurofibromatosis Treatment Market Report 2026

    https://www.thebusinessresearchcompany.com/report/neurofibromatosis-treatment-global-market-report

    Neuralgia Treatment Market Report 2026

    https://www.thebusinessresearchcompany.com/report/neuralgia-treatment-global-market-report

    Muscle Pain Treatment Market Report 2026

    https://www.thebusinessresearchcompany.com/report/muscle-pain-treatment-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Fibromyalgia Treatment Market Emerging Trends and Growth Drivers Through 2029 | Reach USD $3.46 Billion

    Fibromyalgia Treatment Market Emerging Trends and Growth Drivers Through 2029 | Reach USD $3.46 Billion

    Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

    What Is The Present And Forecasted Size Of The Fibromyalgia Treatment Market?

    The market size for fibromyalgia treatment has been on a consistent rise in the previous years. It is projected to increase from $2.79 billion in 2024 to $2.89 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 3.6%. The historical growth is largely due to the increasing instances of fibromyalgia, enhanced understanding of the condition, governmental programs and the growth in disposable incomes.

    The market size for fibromyalgia treatment is projected to experience consistent growth in the upcoming years, expanding to $3.46 billion by 2029 at a compound annual growth rate (CAGR) of 4.6%. The anticipated growth in this period can be linked to factors such as an increasing elderly population, advancement in healthcare spending, the prevalence of musculoskeletal disorders, and escalated efforts in research and development for improved treatments. Key trends anticipated throughout this forecast period include breakthroughs in treatment methods, strategic alliances, technological integration advancements and innovative treatments.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12933&type=smp

    What Drivers Are Accelerating Expansion Of The Fibromyalgia Treatment Market?

    The advancement of the fibromyalgia market is likely to be fuelled by an increase in government initiatives addressing musculoskeletal conditions. These initiatives could be actions, policies, programs, or projects initiated by the government to tackle various societal challenges, boost economic growth, enhance public services, or attain specific national and citizen beneficial objectives. Notably, significant government bodies are adopting numerous strategies to aid patients affected by musculoskeletal disorders. For example, in 2022, as reported by Musculoskeletal Australia, a body based in Australia, the Australian government rolled out the Own Your Health initiative. This program emphasizes comprehensive self-care for patients diagnosed with musculoskeletal disorders over the upcoming four years. Accordingly, the escalation in focus on musculoskeletal conditions through government initiatives invigorates the fibromyalgia market.

    What Are The Primary Segmentation Parameters In The Fibromyalgia Treatment Market?

    The fibromyalgia treatmentmarket covered in this report is segmented –

    1) By Type: Symptomatic Treatment; Targeted Treatment

    2) By Drug Class: Antidepressants; Antiepileptics; Muscle Relaxants; Analgesics; Other Drugs

    3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy

    Subsegments:

    1) By Symptomatic Treatment: Pain Relievers; Antidepressants; Anti-seizure Medications; Sleep Aids; Physical Therapy

    2) By Targeted Treatment: Cognitive Behavioral Therapy (CBT); Lifestyle Modifications; Complementary Therapies; Medications Targeting Specific Symptoms

    How Are Market Trends Influencing Competition In The Fibromyalgia Treatment Market?

    Leaders in the fibromyalgia treatment market are honing their competitive edge by developing innovative technological solutions, like microchip technology, to retain market dominance. This distinctive type of technology uses a microchip for precise nerve stimulation aimed at relieving fibromyalgia symptoms. A case in point occurred in November 2022, when US-based medical equipment producer NeuroMetrix Inc. introduced the Quell Fibromyalgia device via the Pathfinder Program. This trailblazing solution for symptom reduction was the first and only medical device approved by the U.S. Food and Drug Administration (FDA) for the alleviation of fibromyalgia symptoms. It employs transcutaneous electrical nerve stimulation (TENS), facilitated by distinctive microchip technology, to deliver specific, high-intensity nerve stimulation in a compact, wearable device, further enhanced by position and motion sensors.

    Which Players Are Shaping The Competitive Landscape Of The Fibromyalgia Treatment Market?

    Major companies operating in the fibromyalgia treatment market are Pfizer Inc., Johnson and Johnson Services Inc., Roche Holding AG, AbbVie Inc., Novartis AG, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Co. Ltd., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Horizon Therapeutics PLC, Endo International PLC, Amneal Pharmaceuticals Inc., Zydus Lifesciences Limited, Lupin Limited.

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/fibromyalgia-treatment-global-market-report

    What Are The Emerging Regional Trends Driving The Fibromyalgia Treatment Market?

    North America was the largest region in the fibromyalgia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in fibromyalgia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=12933&type=smp

    Browse Through More Reports Similar to the Global Fibromyalgia Treatment Market 2025, By The Business Research Company

    Macular Degeneration Treatment Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/macular-degeneration-treatment-global-market-report

    Age Related Macular Degeneration Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/age-related-macular-degeneration-global-market-report

    Duchenne Muscular Dystrophy Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/duchenne-muscular-dystrophy-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Fibromyalgia Treatment Market Forecast 2025–2034: Where Businesses Should Invest Next

    Fibromyalgia Treatment Market Forecast 2025–2034: Where Businesses Should Invest Next

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    What Are The Forecasted Market Size Estimates For The Fibromyalgia Treatment Market Between 2025 And 2029?

    The fibromyalgia treatment market size has shown consistent expansion in recent years. It is projected to grow from $2.79 billion in 2024 to $2.89 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 3.6%. The historical growth of this market can be attributed to factors such as the increasing prevalence of fibromyalgia, growing awareness regarding the condition, various government initiatives, and rising disposable incomes.

    The fibromyalgia treatment market is anticipated to show consistent expansion over the upcoming years. Its value is expected to reach $3.46 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 4.6%. This growth during the forecast period is primarily driven by factors such as an expanding geriatric population, increasing healthcare expenditure, a rising prevalence of musculoskeletal disorders, and heightened research and development activities focused on improving treatments. Significant trends expected during this period include advancements in treatment options, the formation of strategic collaborations, progress in technology integration, and the emergence of innovative treatments.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12933&type=smp

    What Are The Drivers Pushing New Developments In The Fibromyalgia Treatment Market?

    The fibromyalgia market is projected to grow as a result of increasing government initiatives concerning musculoskeletal conditions. Government initiatives are defined as distinct actions, policies, programs, or projects executed by a government to address various societal issues, foster economic growth, enhance public services, or achieve specific objectives that benefit the country and its citizens. Leading government bodies are putting several initiatives into practice to support patients with musculoskeletal conditions. For example, in 2022, the Australian government introduced the Own Your Health initiative, according to Musculoskeletal Australia, an organization based in Australia. This particular initiative aims to promote overall self-care for individuals dealing with musculoskeletal conditions for the upcoming four years. Hence, the increasing government initiatives on musculoskeletal conditions are a driving factor for the fibromyalgia market.

    What Are The Major Segment Types Covered In The Fibromyalgia Treatment Market?

    The fibromyalgia treatmentmarket covered in this report is segmented –

    1) By Type: Symptomatic Treatment; Targeted Treatment

    2) By Drug Class: Antidepressants; Antiepileptics; Muscle Relaxants; Analgesics; Other Drugs

    3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy

    Subsegments:

    1) By Symptomatic Treatment: Pain Relievers; Antidepressants; Anti-seizure Medications; Sleep Aids; Physical Therapy

    2) By Targeted Treatment: Cognitive Behavioral Therapy (CBT); Lifestyle Modifications; Complementary Therapies; Medications Targeting Specific Symptoms

    Which Ongoing Trends Are Expected To Shape The Fibromyalgia Treatment Market Outlook?

    Companies prominent in the fibromyalgia treatment market are concentrating on developing advanced technological solutions, such as microchip technology, to uphold their market presence. Proprietary microchip technology specifically employs a microchip to deliver accurate and targeted nerve stimulation, aiming to lessen symptoms linked with fibromyalgia. For instance, in November 2022, NeuroMetrix Inc., a US-based medical equipment manufacturing company, launched its Quell Fibromyalgia device through the Pathfinder Program, presenting an innovative method for reducing fibromyalgia symptoms. Quell Fibromyalgia, recognized as the initial and only medical device authorized by the U.S. Food and Drug Administration (FDA) for relieving fibromyalgia symptoms, utilizes transcutaneous electrical nerve stimulation (TENS). This device, made possible by proprietary microchip technology, delivers precise, high-power nerve stimulation in a compact, wearable design, optimized by position and motion sensing.

    Which Key Players Are Driving Competition In The Fibromyalgia Treatment Market?

    Major companies operating in the fibromyalgia treatment market are Pfizer Inc., Johnson and Johnson Services Inc., Roche Holding AG, AbbVie Inc., Novartis AG, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Co. Ltd., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Horizon Therapeutics PLC, Endo International PLC, Amneal Pharmaceuticals Inc., Zydus Lifesciences Limited, Lupin Limited.

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/fibromyalgia-treatment-global-market-report

    What Are The Key Regional Factors Influencing The Fibromyalgia Treatment Market Growth?

    North America was the largest region in the fibromyalgia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in fibromyalgia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    Request A Customized Version Of The Fibromyalgia Treatment Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=12933&type=smp

    Browse Through More Reports Similar to the Global Fibromyalgia Treatment Market 2025, By The Business Research Company

    Macular Degeneration Treatment Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/macular-degeneration-treatment-global-market-report

    Age Related Macular Degeneration Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/age-related-macular-degeneration-global-market-report

    Duchenne Muscular Dystrophy Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/duchenne-muscular-dystrophy-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Fibromyalgia Treatment Market Projected at $3.45 Billion by 2029 | Strategic Insights and Forecast Data

    Fibromyalgia Treatment Market Projected at $3.45 Billion by 2029 | Strategic Insights and Forecast Data

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    How Has the Fibromyalgia Treatment Market Size Changed, over the years?

    The market size for fibromyalgia treatment has experienced steady growth over the recent years. The projection shows a growth from $2.79 billion in 2024 to $2.9 billion in 2025, recording a compound annual growth rate (CAGR) of 3.9%. The growth in the past years can be traced back to the rising occurrence of fibromyalgia, increased awareness about the condition, government efforts, and growing disposable incomes.

    How Much Will the Fibromyalgia Treatment Market Be Worth in 2029?

    In the coming years, the market for fibromyalgia treatment is predicted to experience consistent growth, expanding to $3.45 billion by 2029, with a compound annual growth rate (CAGR) of 4.5%. Factors contributing to the projected growth during the forecast period include an increasing elderly population, heightened healthcare spending, a growing number of musculoskeletal disorder cases, and escalated efforts in research and development to improve treatments. The forecast period will also see significant trends such as progress in treatment methods, strategic partnerships, advancements in the incorporation of technology, and novel treatments.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12933&type=smp

    Which is the Largest Company in the Fibromyalgia Treatment Market?

    Major companies operating in the fibromyalgia treatment market are Pfizer Inc., Johnson and Johnson Services Inc., Roche Holding AG, AbbVie Inc., Novartis AG, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Co. Ltd., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Horizon Therapeutics PLC, Endo International PLC, Amneal Pharmaceuticals Inc., Zydus Lifesciences Limited, Lupin Limited.

    What Are the Main Market Drivers in the Fibromyalgia Treatment Industry?

    The expansion of the fibromyalgia market is likely to be fuelled by increasing governmental efforts addressing musculoskeletal conditions. Such efforts include actions, projects, or policies implemented by governmental bodies to address societal issues, boost economic growth, improve public services, and work towards specific national benefits. For example, Musculoskeletal Australia, noted that the Australian government launched the ‘Own Your Health’ initiative in 2022. This initiative focuses on self-care for individuals with musculoskeletal conditions over the next four years, highlighting the impact of governmental involvement on the fibromyalgia market.

    Market Growth Driver for Fibromyalgia Treatment: An Increase in the Elderly Population Fuels the Fibromyalgia Treatment Market

     

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=12933&type=smp

    How Is the Fibromyalgia Treatment Market Segments Structured?

    The fibromyalgia treatment market covered in this report is segmented –

    1) By Type: Symptomatic Treatment, Targeted Treatment

    2) By Drug Class: Antidepressants, Antiepileptics, Muscle Relaxants, Analgesics, Other Drugs

    3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

    Subsegments:

    1) By Symptomatic Treatment: Pain Relievers, Antidepressants, Anti-seizure Medications, Sleep Aids, Physical Therapy

    2) By Targeted Treatment: Cognitive Behavioral Therapy (CBT), Lifestyle Modifications, Complementary Therapies, Medications Targeting Specific Symptoms

    What Strategic Trends Are Transforming the Fibromyalgia Treatment Market?

    Leading organizations in the fibromyalgia treatment market are concentrating on introducing cutting-edge technological solutions like microchip technology to retain their market dominance. This unique microchip technology application uses a microchip to deliver accurate and focused nerve stimulation to lessen fibromyalgia symptoms. For example, NeuroMetrix Inc., a medical equipment production company based in the United States, unveiled a Quell Fibromyalgia device in November 2022 via the Pathfinder Program. This offers a new approach toward reducing fibromyalgia symptoms. Quell Fibromyalgia is the only FDA-approved medical device for managing fibromyalgia symptoms. It applies Transcutaneous Electrical Nerve Stimulation (TENS), facilitated by distinctive microchip technology. This technology provides accurate, high-intensity nerve stimulation in a small, wearable device, enhanced via position and motion detection.

    Access The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/fibromyalgia-treatment-global-market-report

    Which Global Regions Offer the Highest Growth in the Fibromyalgia Treatment Market?

    North America was the largest region in the fibromyalgia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in fibromyalgia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    Purchase The Full Report Today:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12933

    This Report Delivers Insight On:

    1. How big is the fibromyalgia treatment market, and how is it changing globally?

    2. Who are the major companies in the fibromyalgia treatment market, and how are they performing?

    3. What are the key opportunities and risks in the fibromyalgia treatment market right now?

    4. Which products or customer segments are growing the most in the fibromyalgia treatment market?

    5. What factors are helping or slowing down the growth of the fibromyalgia treatment market?

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 2071930708

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Fibromyalgia Treatment Market Growth Outlook: Trends, Market Size, and Opportunities Over the Next Decade

    Fibromyalgia Treatment Market Growth Outlook: Trends, Market Size, and Opportunities Over the Next Decade

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    What Industry-Specific Factors Are Fueling the Growth of theFibromyalgia Treatment Market?

    The growth of the fibromyalgia market is expected to get a boost from increasing government initiatives focused on managing musculoskeletal diseases. These initiatives are specialized actions, policies, or projects created by the government to tackle societal issues, boost economic development, and enhance public services for the good of the country and its citizens. Notably, significant government entities have taken up several initiatives to provide relief to patients dealing with musculoskeletal conditions. For example, in 2022, the Australian government launched the Own Your Health initiative, as reported by Musculoskeletal Australia, an organization based in Australia. The initiative aims at holistic self-care management for patients with musculoskeletal conditions over the next four years. Hence, the rising number of government directives focusing on musculoskeletal conditions propels the fibromyalgia market.

    Fibromyalgia Treatment Market Driver: Growth of the Fibromyalgia Treatment Market is Propelled by the Increasing Elderly Population

     

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12933&type=smp

    #What is the Anticipated CAGR of theFibromyalgia Treatment Market, and What Factors Will Drive It?

    The market for fibromyalgia treatment has consistently expanded in the past few years. It is projected to increase from a valuation of $2.79 billion in 2024 to around $2.9 billion in 2025, with a compound annual growth rate (CAGR) of 3.9%. Factors influencing this growth have included a rise in fibromyalgia cases, enhanced understanding of the condition, government involvement, and growing disposable incomes.

    In the upcoming years, the fibromyalgia treatment market is anticipated to experience consistent growth, expanding to $3.45 billion by 2029 at a compound annual growth rate (CAGR) of 4.5%. Several factors contributing to this growth in the projected period include an aging population, increased healthcare spending, higher instances of musculoskeletal conditions, and a surge in research and development efforts to improve treatments. The future trajectory of this market will be shaped by emerging trends such as advancements in therapy alternatives, strategic partnerships, technological integration advancements, and innovative treatment methods.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12933

    What Key Market Trends and Innovations Are Shaping the Future of theFibromyalgia Treatment Industry?

    Top-tier companies in the fibromyalgia treatment market are making concerted efforts to develop and integrate state-of-the-art technologies like microchip technology, with the aim of retaining their market dominance. This unique type of technology employs a microchip for pinpoint stimulation of nerves, helping to alleviate fibromyalgia symptoms. A case in point is the November 2022 unveiling of the Quell Fibromyalgia device by NeuroMetrix Inc., a premier medical equipment manufacturer based in the US. Through the Pathfinder Program, this groundbreaking solution for fibromyalgia symptom management was offered. As the first and only medical device approved by the U.S. Food and Drug Administration (FDA) for the relief of fibromyalgia symptoms, the Quell Fibromyalgia device uses the transcutaneous electrical nerve stimulation (TENS) method. Enabled by its own microchip technology, this compact, wearable device delivers targeted, high-level nerve stimulation, further enhanced by position and motion sensing capabilities.

    Which Companies Are Leading the Charge in Expanding theFibromyalgia Treatment Market Growth?

    Major companies operating in the fibromyalgia treatment market are Pfizer Inc., Johnson and Johnson Services Inc., Roche Holding AG, AbbVie Inc., Novartis AG, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Co. Ltd., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Horizon Therapeutics PLC, Endo International PLC, Amneal Pharmaceuticals Inc., Zydus Lifesciences Limited, Lupin Limited.

    Order Your Report Now For A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/fibromyalgia-treatment-global-market-report

    How is the Global Fibromyalgia Treatment Market Segemented?

    The fibromyalgia treatment market covered in this report is segmented –

    1) By Type: Symptomatic Treatment, Targeted Treatment

    2) By Drug Class: Antidepressants, Antiepileptics, Muscle Relaxants, Analgesics, Other Drugs

    3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

    Subsegments:

    1) By Symptomatic Treatment: Pain Relievers, Antidepressants, Anti-seizure Medications, Sleep Aids, Physical Therapy

    2) By Targeted Treatment: Cognitive Behavioral Therapy (CBT), Lifestyle Modifications, Complementary Therapies, Medications Targeting Specific Symptoms

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=12933&type=smp

    Which Geographics are Influencing the Growth of the Fibromyalgia Treatment Market?

    North America was the largest region in the fibromyalgia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in fibromyalgia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    Browse Through More Reports Similar to the Global Fibromyalgia Treatment Market 2025, By The Business Research Company:

    Brain And Neuroimaging Devices Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/brain-and-neuroimaging-devices-global-market-report

    Interventional Neurology Devices And Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/interventional-neurology-devices-and-equipment-global-market-report

    Central Nervous System Biomarkers Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/central-nervous-system-biomarkers-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Comprehensive Analysis of the Fibromyalgia Treatment Market 2025-2034: Growth Rates, Trends, and Future Opportunities

    Comprehensive Analysis of the Fibromyalgia Treatment Market 2025-2034: Growth Rates, Trends, and Future Opportunities

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    How has the Fibromyalgia Treatment market grown in recent years?

    The market size for fibromyalgia treatment has seen steady growth in the recent years. Projected to rise from $2.79 billion in 2024 to $2.9 billion in the following year, it presents a compound annual growth rate (CAGR) of 3.9%. This progression during the historic period is tied to a growing number of fibromyalgia cases, increased public awareness about the condition, various government interventions, and an upsurge in disposable incomes.

    How is the fibromyalgia treatment market size expected to evolve during the forecast period?

    Expectations for the fibromyalgia treatment market size indicate a consistent expansion in the ensuing years. This market is projected to reach $3.45 billion by 2029, with a compound annual growth rate (CAGR) of 4.5%. The projected growth during this period is linked to factors such as a rising aging population, increases in healthcare spending, escalating incidences of musculoskeletal diseases, and enhanced research and development efforts to improve treatment solutions. Notable trends throughout the forecast period include advancements in therapeutic choices, strategic partnerships, progressive technology integration, and the emergence of innovative treatments.

    Get your fibromyalgia treatment market report here!

    https://www.thebusinessresearchcompany.com/report/fibromyalgia-treatment-global-market-report

    Which key drivers are propelling the fibromyalgia treatment market’s growth?

    Government measures specifically targeting musculoskeletal disorders are anticipated to fuel future growth in the fibromyalgia market. These initiatives, which can range from policies and programs to specialized projects, are designed by governments to meet the varying needs of their citizens, stimulate economic growth, enhance the quality of public services, and achieve specific objectives that are in the nation’s interest. Top governing bodies are focusing on these initiatives to deliver necessary aid to those afflicted with musculoskeletal conditions. Musculoskeletal Australia, an Australian organization, reported in 2022 that the nation’s government launched the Own Your Health initiative, a program dedicated to promoting self-care for people suffering from musculoskeletal illnesses for the next quadrennial. Thus, the fibromyalgia market benefits from these increasing government interventions on musculoskeletal disorders. An increase in the elderly population is anticipated to accelerate the growth of the fibromyalgia treatment market. This refers to the rise in the percentage of old age people in a particular society or population, a demographic trend. Treating fibromyalgia becomes increasingly essential for older individuals, as they are more prone to develop fibromyalgia, and their symptoms are usually harsher due to factors related to aging. The United Nations Department of Economic and Social Affairs, a US-based entity, noted in July 2022 that the percentage of people on a global scale who are 65 years old or more is projected to climb from 10% in 2022 to 16% in 2050. Therefore, an increase in the older population spurs the growth of the fibromyalgia treatment market.

    What are the market segments in the fibromyalgia treatment industry?

    The fibromyalgia treatment market covered in this report is segmented –

    1) By Type: Symptomatic Treatment, Targeted Treatment

    2) By Drug Class: Antidepressants, Antiepileptics, Muscle Relaxants, Analgesics, Other Drugs

    3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

    Subsegments:

    1) By Symptomatic Treatment: Pain Relievers, Antidepressants, Anti-seizure Medications, Sleep Aids, Physical Therapy

    2) By Targeted Treatment: Cognitive Behavioral Therapy (CBT), Lifestyle Modifications, Complementary Therapies, Medications Targeting Specific Symptoms

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12933&type=smp

    Which leading companies are shaping the growth of the fibromyalgia treatment market?

    Major companies operating in the fibromyalgia treatment market are Pfizer Inc., Johnson and Johnson Services Inc., Roche Holding AG, AbbVie Inc., Novartis AG, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Co. Ltd., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Horizon Therapeutics PLC, Endo International PLC, Amneal Pharmaceuticals Inc., Zydus Lifesciences Limited, Lupin Limited.

    What key trends are currently impacting the fibromyalgia treatment market’s development?

    The key players within the fibromyalgia treatment market are prioritizing the development of cutting-edge solutions, such as microchip technology, to maintain their market share. This unique microchip technology uses a chip to deliver accurate, targeted nerve stimulation to alleviate fibromyalgia symptoms. For example, in November 2022, NeuroMetrix Inc., an American medical equipment manufacturer, introduced the Quell Fibromyalgia device via the Pathfinder Program, providing an innovative solution for reducing fibromyalgia symptoms. Authorized by the U.S Food and Drug Administration (FDA) as the first and only medical device to alleviate fibromyalgia symptoms, the Quell Fibromyalgia uses transcutaneous electrical nerve stimulation (TENS). This device, powered by proprietary microchip technology, provides precise, high-power nerve stimulation in a small, wearable form, optimized through position and motion sensing.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12933

    Which geographic areas are influencing the growth of the fibromyalgia treatment market?

    North America was the largest region in the fibromyalgia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in fibromyalgia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    Browse Through More Similar Reports By The Business Research Company:

    Brain And Neuroimaging Devices Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/brain-and-neuroimaging-devices-global-market-report

    Interventional Neurology Devices And Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/interventional-neurology-devices-and-equipment-global-market-report

    Central Nervous System Biomarkers Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/central-nervous-system-biomarkers-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on: